Ahmad I, Del Debbio CB, Das AV, Parameswaran S (2011) Müller glia: a promising target for therapeutic regeneration. Invest Ophth Vis Sci 52:5758–5764
CAS
Google Scholar
Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS, Kester M, Kimball SR, Krady JK, LaNoue KF, Norbury CC, Quinn PG, Sandirasegarane L, Simpson IA (2006) Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55:2401–2411
CAS
PubMed
Google Scholar
Barber A, Antonetti DT (2000) Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. Invest Ophth Vis Sci 41:3561–3568
CAS
Google Scholar
Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412
CAS
PubMed
Google Scholar
Boldt S, Weidle UH, Kolch W (2002) The role of MAPK pathways in the action of chemotherapeutic drugs. Carcinogenesis 23:1831–1838
CAS
PubMed
Google Scholar
Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625
CAS
PubMed
Google Scholar
Cai X, Li J, Wang M, She M, Tang Y, Li J, Li H, Hui H (2017) GLP-1 treatment improves diabetic retinopathy by alleviating autophagy through GLP-1R-ERK1/2-HDAC6 signaling pathway. Int J Med Sci 14:1203–1212
CAS
PubMed
PubMed Central
Google Scholar
Calcutt NA, Cooper ME, Kern TS, Schmidt AM (2009) Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials. Nat Rev Drug Discov 8:417–429
CAS
PubMed
PubMed Central
Google Scholar
Chen KJ (2012) Blood stasis syndrome and its treatment with activating blood circulation to remove blood stasis therapy. Chin J Integr Med 18:891–896
PubMed
Google Scholar
Chen Q, Olashaw N, Wu J (1995) Participation of reactive oxygen species in the lysophosphatidic acid-stimulated mitogen-activated protein kinase kinase activation pathway. J Biol Chem 270:28499–28502
CAS
PubMed
Google Scholar
Chen KJ, Shi DZ, Fu CG, Gao ZY, Xu H, Lv SZ, You SJ, Huang L (2016) Diagnostic criterion of blood stasis syndrome for coronary heart disease: activating Blood Circulation Committee of Chinese Association of Integrative Medicine. Chin J Integr Med 22:803–804
PubMed
Google Scholar
Ding H, Hashem M, Triggle C (2007) Increased oxidative stress in the streptozotocin-induced diabetic apoE-deficient mouse: changes in expression of NADPH oxidase subunits and eNOS. Eur J Pharmacol 561:121–128
CAS
PubMed
Google Scholar
Fang D, Wan X, Deng W, Guan H, Ke W, Xiao H, Li Y (2012) Fufang Xue Shuan Tong capsules inhibit renal oxidative stress markers and indices of nephropathy in diabetic rats. Exp Ther Med 4:871–876
PubMed
PubMed Central
Google Scholar
Gabryel B, Pudelko A, Adamczyk J, Fischer I, Malecki A (2006) Calcineurin and Erk1/2-signaling pathways are involved in the antiapoptotic effect of cyclosporin A on astrocytes exposed to simulated ischemia in vitro. Naunyn Schmiedebergs Arch Pharmacol 374:127–139
CAS
PubMed
Google Scholar
Gao L, Mann GE (2009) Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res 82:9–20
CAS
PubMed
Google Scholar
Gerhardinger C, Costa MB, Coulombe MC, Toth I, Hoehn T, Grosu P (2005) Expression of acute-phase response proteins in retinal Müller cells in diabetes. Invest Ophthalmol Vis Sci 46:349–357
PubMed
Google Scholar
Guyton KZ, Liu Y, Gorospe M, Xu Q, Holbrook NJ (1996) Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem 271:4138–4142
CAS
PubMed
Google Scholar
Hans-Peter H, Feng Y, Frederick P, Michael B (2011) Diabetic retinopathy: targeting vasoregression. Diabetes 60:9–16
Google Scholar
Hernández C, Simóservat A, Bogdanov P, Simó R (2017) Diabetic retinopathy: new therapeutic perspectives based on pathogenic mechanisms. J Endocrinol Invest 40:1–11
Google Scholar
Hossain A, Heron D, Davenport I, Huckaba T, Graves R, Mandal T, Muniruzzaman S, Wang S, Bhattacharjee PS (2016) Protective effects of bestatin in the retina of streptozotocin-induced diabetic mice. Exp Eye Res 149:100–106
CAS
PubMed
PubMed Central
Google Scholar
Johansen JS, Harris AK, Rychly DJ, Ergul A (2005) Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol 4:5
PubMed
PubMed Central
Google Scholar
Klein R, Klein BEK, Moss SE, Davis MD, Demets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520–526
CAS
PubMed
Google Scholar
Kowluru RA, Chan PS (2007) Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007:43603
PubMed
PubMed Central
Google Scholar
Kowluru RA, Engerman RL, Case GL, Kern TS (2001) Retinal glutamate in diabetes and effect of antioxidants. Neurochem Int 38:385–390
CAS
PubMed
Google Scholar
Kumari S, Panda S, Mangaraj M, Mandal MK, Mahapatra PC (2008) Plasma MDA and antioxidant vitamins in diabetic retinopathy. Indian J Clin Biochem 23:158–162
CAS
PubMed
PubMed Central
Google Scholar
Kuo CW, Shen CJ, Tung YT, Chen HL, Chen YH, Chang WH, Cheng KC, Yang SH, Chen CM (2015) Extracellular superoxide dismutase ameliorates streptozotocin-induced rat diabetic nephropathy via inhibiting the ROS/ERK1/2 signaling. Life Sci 135:77–86
CAS
PubMed
Google Scholar
Lander HM (1997) An essential role for free radicals and derived species in signal transduction. FASEB J 11:118–124
CAS
PubMed
Google Scholar
Lee HB, Yu MR, Yang Y, Jiang Z, Ha H (2003) Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 14:241–245
Google Scholar
Liao J, Liu Y, Jie W (2016) Erratum to: identification of more objective biomarkers for blood-stasis syndrome diagnosis. BMC Complement Altern Med 16:371
PubMed
PubMed Central
Google Scholar
Luo DW, Zheng Z, Wang H, Fan Y, Chen F, Sun Y, Wang WJ, Sun T, Xu X (2015) UPP mediated diabetic retinopathy via ROS/PARP and NF-κB inflammatory factor pathways. Curr Mol Med 15:790–799
CAS
PubMed
Google Scholar
Mizutani M, Gerhardinger C, Lorenzi M (1998) Müller cell changes in human diabetic retinopathy. Diabetes 47:445
CAS
PubMed
Google Scholar
Musiolik J, Van CP, Skyschally A, Boengler K, Gres P, Schulz R et al (2010) Reduction of infarct size by gentle reperfusion without activation of reperfusion injury salvage kinases in pigs. Cardiovasc Res 85:110–117
CAS
PubMed
Google Scholar
Pei R, Gao H (2015) Clinical effects and hs-CRP, VEGF and IGF-1 levels of Xueshuantong capsule combined with calcium dobesilate in treatment of early diabetic retinopathy. Modern J Integr Tradit Chin Western Med 24:3896–3907
Google Scholar
Shi X, Zhu H, Zhang Y, Zhou M, Tang D, Zhang H (2017) XuefuZhuyu decoction protected cardiomyocytes against hypoxia/reoxygenation injury by inhibiting autophagy. BMC Complem Altern Med 17:325
Google Scholar
Simó R, Hernández C (2014) Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives. Trends Endocrinol Metab 25:23–33
PubMed
Google Scholar
Stewart MW (2017) A review of ranibizumab for the treatment of diabetic retinopathy. Ophthalmol Ther 6:33–47
PubMed
PubMed Central
Google Scholar
Takahashi N, Saito Y, Kuwahara K, Harada M, Tanimoto K, Nakagawa Y, Kawakami R, Nakanishi M, Yasuno S, Usami S, Yoshimura A, Nakao K (2005) Hypertrophic responses to cardiotrophin-1 are not mediated by STAT3, but via a MEK5-ERK5 pathway in cultured cardiomyocytes. J Mol Cell Cardiol 38:185–192
CAS
PubMed
Google Scholar
Tien T, Zhang J, Muto T, Kim D, Sarthy VP, Roy S (2017) High glucose induces mitochondrial dysfunction in retinal müller cells: implications for diabetic retinopathy. Invest Ophth Vis Sci 58:2915–2921
CAS
Google Scholar
Valverde AM, Soledad M, Marta GR, Águeda GR, Cristina H, Rafael S (2013) Proapoptotic and survival signaling in the neuroretina at early stages of diabetic retinopathy. Mol Vis 19:47–53
CAS
PubMed
PubMed Central
Google Scholar
van Dijk HW, Verbraak FD, Kok PH, Stehouwer M, Garvin MK, Sonka M, DeVries JH, Schlingemann RO, Abràmoff MD (2012) Early neurodegeneration in the retina of type 2 diabetic patients. Invest Ophthalmol Vis Sci 53:2715–2719
PubMed
PubMed Central
Google Scholar
Wang Y, Chun LI, Wen-Jing C, Guo SZ, Wang W (2011) Experimental study on role of AngII-NADPH oxidase-ROS pathway in syndrome of blood stasis based on chronic myocardial ischemia model. China J Tradit Chin Med Pharm 26:2265–2268
CAS
Google Scholar
Xing Z, Xia Z, Peng W, Li J, Zhang C, Fu C, Tao T, Luo J, Yong Z, Rong F (2016) Xuefu Zhuyu decoction, a traditional Chinese medicine, provides neuroprotection in a rat model of traumatic brain injury via an anti-inflammatory pathway. Sci Rep 6:20040
CAS
PubMed
PubMed Central
Google Scholar
Yang MM, Wang J (2011) Preventive and therapeutic effect of Salvia miltiorrhiza for diabetic retinopathy. J Harbin Med Univ 45:553–555
CAS
Google Scholar
Ye X, Ren H, Zhang M, Sun Z, Jiang AC, Xu G (2012) ERK1/2 signaling pathway in the release of VEGF from Müller cells in diabetes. Invest Ophthalmol Vis Sci 53:3481–3489
CAS
PubMed
Google Scholar
Yin DH, Liang XC, Piao YL (2009) Analysis of chinese medicine syndrome pattern in patients with type 2 diabetes mellitus and its relationship with diabetic chronic complications. Chin J Integr Tradit Western Med 29:506–510
CAS
Google Scholar
Yue SJ, Xin LT, Fan YC, Li SJ, Tang YP, Duan JA, Guan HS, Wang CY (2017) Herb pair Danggui-Honghua: mechanisms underlying blood stasis syndrome by system pharmacology approach. Sci Rep 7:40318
CAS
PubMed
PubMed Central
Google Scholar
Zhao H, Chen J, Shi Q, Ma X, Yang Y, Luo L, Guo S, Wang Y, Han J, Wang W (2012) Metabolomics-based study of clinical and animal plasma samples in coronary heart disease with blood stasis syndrome. Evid Based Compl Alt 2012:638723
Google Scholar
Zhou YN, Sun MY, Mu YP, Yang T, Ning BB, Ren S, Chen JM, Liu P (2014) Xuefuzhuyu decoction inhibition of angiogenesis attenuates liver fibrosis induced by CCl4 in mice. J Ethnopharmacol 153:659–666
PubMed
Google Scholar